Hypoxia-targeted radiotherapy dose painting for head and neck cancer using 18F-FMISO PET: A biological modeling study

Acta Oncologica

Volumn 52, Issue 8, 2013, Pages 1723-1729

  Chang, Joe H ^a,b   Wada, Morikatsu ^a   Anderson, Nigel J ^a   Lim Joon, Daryl ^a,b   Lee, Sze Ting ^a,b,c   Gong, Sylvia J ^a   Gunawardana, Dishan H ^a   Sachinidis, John ^a   O'Keefe, Graeme ^a   Gan, Hui K ^a,c   Khoo, Vincent ^a,b,d   Scott, Andrew M ^a,b,c  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; FLUORINE 18; FLUORINE 18 FLUOROMISONIDAZOLE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; HYPOXIA; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE ESCALATION; BRAIN STEM; CANCER CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; INTENSITY MODULATED RADIATION THERAPY; MANDIBLE; MIDDLE AGED; PET SCANNER; SPINAL CORD; TREATMENT PLANNING;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; COHORT STUDIES; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MISONIDAZOLE; MODELS, BIOLOGICAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84884545637     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.759273     Document Type: Article

References (23)

1. Joiner MC, Van der Kogel AJ, editors. Basic clinical radiobiology. 4th ed. london: Hodder Arnold; 2009.
2. Janssen HL, Haustermansk M, Balm AJ, Begg AC. Hypoxia in head and neck cancer: How much, how important? Head neck 2005;27:622-38.
3. Overgaard J. Hypoxic modifcation of radiotherapy in squa-mous cell carcinoma of the head and neck-A systematic review and meta-analysis. Radiother Oncol 2011;100:22-32.
4. Chao KS, Ozyigit G, Tran BN, Cengiz M, dempsey JF, Low DA. Patterns of failure in patients receiving defnitive and postoperative iMRT for head-and-neck cancer. int J Radiat Oncol Biol Phys 2003;55:312-21.
5. Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. int J Radiat Oncol Biol Phys 2000;46:1117-26.
6. Zimny M, Gagel B, diMartino E, Hamacher K, Coenen HH, Westhofen M, et al. Fdg-a marker of tumour hypoxia? A comparison with [18F]fuoromisonidazole and pO2-polarography in metastatic head and neck cancer. Eur J nucl Med Mol imaging 2006;33:1426-31.
7. Lee ST, Scott AM. Hypoxia positron emission tomography imaging with 18F-fuoromisonidazole. semin nucl Med 2007;37:451-61.
8. Popple RA, Ove R, Shen S. Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation. int J Radiat Oncol Biol Phys 2002; 54:921-7.
9. Cher LM, Murone C, Lawrentschuk N, Ramdave S, Papenfuss A, Hannah A, et al. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fuoromisonidazole, 18F-Fdg PET, and immunohistochemical studies. J nucl Med 2006;47:410-8.
10. Lee N. A phase ii study of concurrent chemoradiotherapy using three-dimensional conformal radiotherapy (3d-CRT) or intensity-modulated radiation therapy (iMRT) + bevacizumab (BV) for locally or regionally advanced nasopharyngeal cancer. RTOg 0615 [internet]. 2011 [updated 2011 Feb 16; cited 2012 Jun 20]. Available from: http://www.rtog.org/ClinicalTrials/ProtocolTable/ study details.aspx?study = 0615.
11. Sanchez-Nieto B, Nahum AE. BiOPlAn: software for the biological evaluation of radiotherapy treatment plans. Med dosim 2000;25:71-6.
12. Avanzo M, Stancanello J, Franchin G, Sartor G, Jena R, Drigo A, et al. Correlation of a hypoxia based tumor control model with observed local control rates in nasopharyngeal carcinoma treated with chemoradiotherapy. Med Phys 2010;37:1533-44.
13. Fowler JF. Correction to kasibhatla et al. How much radiation is the chemotherapy worth in advanced head and neck cancer? (int J Radiat Oncol Biol Phys 2007;68:1491-5). int J Radiat Oncol Biol Phys 2008;71:326-9.
14. Carlson DJ, Stewart Rd, Semenenko VA. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (lQ) model parameters. Med Phys 2006;33:3105-15.
15. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. int J Radiat Oncol Biol Phys 1991;21:123-35.
16. Semenenko VA, Li XA. lyman-kutcher-Burman nTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data. Phys Med Biol 2008;53:737-55.
17. Agren A, Brahme A, Turesson I. Optimization of uncomplicated control for head and neck tumors. int J Radiat Oncol Biol Phys 1990;19:1077-85.
18. Thorwarth D, Eschmann SM, Paulsen F, Alber M. Hypoxia dose painting by numbers: A planning study. int J Radiat Oncol Biol Phys 2007;68:291-300.
19. Hendrickson K, Phillips M, Smith W, Peterson L, Krohn K, Rajendran J. Hypoxia imaging with [F-18] FMisO-PET in head and neck cancer: Potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance. Radiother Oncol 2011; 101: 369-75.
20. Lin Z, Mechalakos J, Nehmeh S, Schoder H, Lee N, Humm J, et al. The infuence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMisO positron emission tomography. int J Radiat Oncol Biol Phys 2008;70:1219-28.
21. Eschmann SM, Paulsen F, Bedeshem C, Machulla HJ, Hehr T, Bamberg M, et al. Hypoxia-imaging with (18)F-Misonida-zole and PET: Changes of kinetics during radiotherapy of head-and-neck cancer. Radiother Oncol 2007;83: 406-10.
22. Duprez F, De Neve W, De Gersem W, Coghe M, Madani I. Adaptive dose painting by numbers for head-and-neck cancer. int J Radiat Oncol Biol Phys 2011;80:1045-55.
23. Madani I, duthoy W, Derie C, de Gersem W, Boterberg T, Saerens M, et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. int J Radiat Oncol Biol Phys 2007;68:126-35.